Stock On Watch: Humana Inc (NYSE:HUM) Institutional Investors Sentiment

November 25, 2016 - By Marguerite Chambers   ·   0 Comments

Stock On Watch: Humana Inc (NYSE:HUM) Institutional Investors Sentiment

Sentiment for Humana Inc (NYSE:HUM)

Humana Inc (NYSE:HUM) institutional sentiment decreased to 0.91 in 2016 Q2. Its down -0.19, from 1.1 in 2016Q1. The ratio dived, as 237 investment managers opened new or increased holdings, while 215 cut down and sold their stock positions in Humana Inc. The investment managers in our partner’s database now hold: 135.64 million shares, down from 142.65 million shares in 2016Q1. Also, the number of investment managers holding Humana Inc in their top 10 holdings decreased from 23 to 21 for a decrease of 2. Sold All: 43 Reduced: 172 Increased: 178 New Position: 59.

Humana Inc. is a health and well-being company. The company has a market cap of $31.33 billion. The Company’s divisions include Retail, Group, Healthcare Services and Other Businesses. It has a 28.1 P/E ratio. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

The stock decreased 0.02% or $0.05 during the last trading session, hitting $207.88. About 498,366 shares traded hands. Humana Inc (NYSE:HUM) has risen 18.61% since April 22, 2016 and is uptrending. It has outperformed by 13.20% the S&P500.

Analysts await Humana Inc (NYSE:HUM) to report earnings on February, 8. They expect $2.17 earnings per share, up 49.66% or $0.72 from last year’s $1.45 per share. HUM’s profit will be $327.04M for 23.95 P/E if the $2.17 EPS becomes a reality. After $3.18 actual earnings per share reported by Humana Inc for the previous quarter, Wall Street now forecasts -31.76% negative EPS growth.

According to Zacks Investment Research, “Humana, Inc. is a health services company that facilitates the delivery of health care services through networks of providers to its medical members. The company’s products are marketed primarily through health maintenance organizations and preferred provider organizations that encourage or require the use of contracted providers. The company also offers various specialty products to employers, including dental, group life and workers’ compensation, and administrative services to those who self-insure their employee health plans.”

Glenview Capital Management Llc holds 11.02% of its portfolio in Humana Inc for 8.67 million shares. Arrowgrass Capital Partners (Us) Lp owns 3.73 million shares or 7.13% of their US portfolio. Moreover, Litespeed Management L.L.C. has 7.11% invested in the company for 204,000 shares. The New York-based Jet Capital Investors L P has invested 7.1% in the stock. Twin Securities Inc., a New York-based fund reported 186,159 shares.#img1#

Humana Inc (NYSE:HUM) Ratings Coverage

Ratings analysis reveals 57% of Humana’s analysts are positive. Out of 7 Wall Street analysts rating Humana, 4 give it “Buy”, 0 “Sell” rating, while 3 recommend “Hold”. The lowest target is $150 while the high is $224. The stock’s average target of $187.57 is -9.77% below today’s ($207.88) share price. HUM was included in 17 notes of analysts from July 30, 2015. JP Morgan initiated the stock with “Overweight” rating in Wednesday, September 16 report. The company was maintained on Friday, July 22 by FBR Capital. The stock has “Outperform” rating given by RBC Capital Markets on Friday, July 22. As per Friday, November 11, the company rating was upgraded by Credit Suisse. The rating was maintained by Barclays Capital on Thursday, July 30 with “Equal Weight”. As per Monday, July 18, the company rating was upgraded by Jefferies. The stock of Humana Inc (NYSE:HUM) has “Neutral” rating given on Tuesday, August 16 by Credit Suisse. JP Morgan downgraded it to “Neutral” rating and $150 target price in Friday, July 8 report. Barclays Capital maintained the shares of HUM in a report on Thursday, August 4 with “Equal-Weight” rating. The stock of Humana Inc (NYSE:HUM) has “Neutral” rating given on Wednesday, December 16 by Credit Suisse.

HUM Company Profile

Humana Inc. (Humana), incorporated on July 27, 1964, is a health and well-being company. The Company’s medical and specialty insurance products allow members to access healthcare services primarily through its networks of healthcare providers. The Company’s divisions include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, well-known provider services, home services and clinical programs, as well as services and capabilities to advance population health. The Other Businesses segment includes its closed-block long-term care insurance policies.

More news for Humana Inc (NYSE:HUM) were recently published by: Businesswire.com, which released: “Humana Wins Two Stevie® Awards for Women in Business” on November 21, 2016. Businesswire.com‘s article titled: “Humana Distributes More Than $93 Million in Quality Payments to Providers …” and published on November 16, 2016 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Marguerite Chambers


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>